Mario Draghi’s report, a focus on the proposed actions for the pharma sector
by Giuliana Miglierini The report on the Future of European competitiveness was presented by Mario Draghi on 17…
The new European Supply Chain Law and a Transatlantic partnership
September 6, 2024 by Giuliana Miglierini The new EU Corporate Sustainability Due Diligence Directive (EU) 2024/1760 (CSDDD), also…
The current status of the transition to the MDR and IVDR regulations
by Giuliana Miglierini As the term to apply for the certification of medical devices and in vitro diagnostics…
The proposals of the EU Commission for the revision of the IP legislation
By Giuliana Miglierini In parallel to the new pharmaceutical legislation, on 27 April 2023 the EU Commission issued…
MDCG, a position paper on the capacity of notified bodies
by Giuliana Miglierini The lack of a suitable capacity of notified bodies (NBs) is one of the main…